|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
KYN | Baker James C | President | Jun 27 '25 | Buy | 12.59 | 25,000 | 314,845 | 786,040 | Jun 27 02:41 PM |
KYN | Baker James C | President | Apr 04 '25 | Buy | 11.41 | 25,000 | 285,250 | 761,040 | Apr 07 02:01 PM |
KYN | Baker James C | President | Mar 12 '25 | Buy | 12.27 | 20,000 | 245,400 | 720,939 | Mar 12 02:58 PM |
KYN | Baker James C | President | Feb 28 '25 | Buy | 12.60 | 20,000 | 252,000 | 700,939 | Mar 03 02:49 PM |
KYN | Baker James C | President | Jan 10 '24 | Buy | 8.84 | 50,000 | 441,800 | 681,039 | Jan 10 02:51 PM |
KYN | Baker James C | President | Nov 30 '23 | Buy | 8.50 | 40,000 | 340,008 | 631,039 | Nov 30 01:21 PM |
KYN | Baker James C | President | Nov 28 '23 | Buy | 10.03 | 37,547 | 376,596 | 591,039 | Nov 29 04:29 PM |
KYN | Baker James C | President | Mar 29 '23 | Buy | 8.39 | 10,000 | 83,900 | 374,424 | Mar 29 03:31 PM |
KYN | Baker James C | President | Jun 09 '20 | Buy | 6.59 | 10,000 | 65,931 | 359,424 | Jun 10 03:58 PM |
KYN | Baker James C | President | Jun 10 '20 | Buy | 6.14 | 5,000 | 30,682 | 364,424 | Jun 10 03:58 PM |
KYN | Baker James C | President | Dec 23 '19 | Buy | 14.16 | 50,000 | 708,000 | 349,424 | Dec 26 12:25 PM |
KYN | Baker James C | President | Jun 28 '19 | Buy | 15.26 | 20,000 | 305,234 | 298,564 | Jul 01 03:13 PM |
KYN | Baker James C | President | May 22 '19 | Buy | 15.83 | 40,000 | 633,200 | 278,437 | May 24 11:24 AM |
KYN | Baker James C | President | Dec 26 '18 | Buy | 12.76 | 20,000 | 255,200 | 237,039 | Dec 27 12:29 PM |
KYN | Baker James C | President | Dec 21 '18 | Buy | 13.67 | 10,000 | 136,742 | 217,039 | Dec 21 02:32 PM |
KYN | Baker James C | President | Dec 17 '18 | Buy | 14.89 | 10,000 | 148,900 | 207,039 | Dec 17 04:14 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite